Jubilant Cadista Pharmaceuticals Inc. recalls Cadista — Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg
- Recall date
- July 23, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Jubilant Cadista Pharmaceuticals Inc., Cadista
Why it was recalled
Due to out of specification (OOS) dissolution results at the 3-month stability time point — Defect
What was recalled
Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg
Read the official recall notice →
Get recall alerts
Free email alert whenever Jubilant Cadista Pharmaceuticals Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Jubilant Cadista Pharmaceuticals Inc., Cadista